- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Decibel Therapeutics Stock (NASDAQ:DBTX), Quotes and News Summary
Decibel Therapeutics Stock (NASDAQ: DBTX)
| Day Range2.93 - 3.3 | 52 Wk Range1.83 - 5.78 | Open / Close3 / 2.96 | Float / Outstanding15.7M / 25M |
| Vol / Avg.58.2K / 65.7K | Mkt Cap73.9M | P/E- | 50d Avg. Price4.37 |
| Div / Yield- | Payout Ratio- | Total Float15.7M | EPS-0.68 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-09 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.570 | -0.680 | -0.1100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Decibel Therapeutics Questions & Answers
You can purchase shares of Decibel Therapeutics (NASDAQ: DBTX) through any online brokerage.
Other companies in Decibel Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Lumos Pharma (NASDAQ:LUMO), Gemini Therapeutics (NASDAQ:GMTX) and Gelesis Holdings (NYSE:GLS).
The latest price target for Decibel Therapeutics (NASDAQ: DBTX) was reported by Citigroup on Tuesday, May 17, 2022. The analyst firm set a price target for 15.00 expecting DBTX to rise to within 12 months (a possible 406.76% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Decibel Therapeutics (NASDAQ: DBTX) is $2.96 last updated Today at October 7, 2022, 8:00 PM UTC.
There are no upcoming dividends for Decibel Therapeutics.
Decibel Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Decibel Therapeutics.
Decibel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.